Icenticaftor | m-entrepreneurship.com

Product Name :
Icenticaftor

Search keywords :
Icenticaftor

drugId :
null

Target Vo:
Cystic fibrosis transmembrane conductance regulator

Target Vo Short Name :
CFTR

Moa_Name:
Cystic fibrosis transmembrane conductance regulator stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
China Novartis Institutes For Biomedical Research Co Ltd

Active Indication_Name:
Bronchiectasis

In Active Indication_Name:
Cystic Fibrosis

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Teplizumab Autophagy
Tarcocimab VEGFR
FGFR1 Oncogene Partner Antibody: FGFR1 Oncogene Partner Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to FGFR1 Oncogene Partner. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts